Macro Finance
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers
Bloomberg Markets·September 21, 2026·1 min read
Novo Nordisk shares fell as investors sought concrete turnaround plans from CEO Mike Doustdar after losing obesity market lead to Eli Lilly, despite pledges of five blockbusters and $23B in new sales. Arhaus rose on a Jefferies upgrade to buy. Accenture gained after Anthropic partnered with it to embed safety evaluators in AI model testing.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.